COVID-19 in Tralokinumab-Treated Patients With Moderate-to- Severe Atopic Dermatitis: Case Series from the ECZTEND Long- Term Extension Trial. J of Skin 2021, 5 (6), s58. https://doi.org/10.25251/skin.5.supp.58.